ImmuCell Corporation
ICCC | NASDAQ
$10.26
-$0.06 (-0.58%)
At close: Oct 30, 2026, 4:00 PM ET
$10.26
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $93.18M
Enterprise Value $96.77M
Beta 0.57
Average Volume 21.64K
Shares Outstanding (Diluted) 9.19M
Shares Change YoY 1.75%
Institutional Ownership 14.71%
Exchange NASDAQ
ISIN US4525253062
Price Performance
Price Change 1M 4.7%
Price Change 3M -8.5%
Price Change 6M 17.5%
Price Change YTD 66.8%
Price Change 1Y 64.4%
Price Change 3Y 103.2%
Price Change 5Y 16.6%
1M CAGR (ann.) 3.1%
1Y CAGR (ann.) 70.2%
5Y CAGR (ann.) 1.9%
All-Time CAGR 6.3%
Valuation
PE Ratio 121.28
Forward PE N/A
PEG Ratio -0.31
Forward PEG -0.31
PS Ratio 3.04
Forward PS 4.90
PB Ratio 2.97
P/FCF Ratio 22.11
P/Adj. FCF Ratio 25.46
P/OCF Ratio 15.78
EV/Sales 3.15
EV/EBIT 84.01
EV/EBITDA 27.37
EV/FCF 22.96
Earnings Yield 0.8%
FCF Yield 4.5%
Adj. FCF Yield 3.9%
Financial Health
Net Cash $557.32K
Total Debt $12.45M
Cash & Short-Term Investments $8.86M
Total Assets $46.63M
Current Ratio 4.75
Quick Ratio 2.71
Debt / Equity Ratio 0.40
Debt / EBITDA 3.52
Debt / FCF 2.95
OCF / Debt 0.47
Interest Coverage 8.93
Altman Z-Score 4.49
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 40.3%
Operating Profit Margin 12.6%
EBITDA Margin 11.5%
Net Profit Margin 2.6%
FCF Margin 13.7%
Adj. FCF Margin 11.9%
SBC / Revenue 1.8%
SBC Impact (per share) -13.2%
Returns
Return on Assets 1.7%
Return on Equity 2.7%
Return on Invested Capital 8.1%
Return on Capital Employed 9.2%
Return on Tangible Assets 1.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 25.1%
Revenue CAGR 5Y 13.7%
Revenue CAGR 10Y 11.3%
EPS CAGR 3Y 361.0%
EPS CAGR 5Y 53.4%
EPS CAGR 10Y -11.6%
FCF CAGR 3Y 151.7%
FCF CAGR 5Y 1.2%
FCF CAGR 10Y -28.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) $0.05
EPS Growth Est (next Q) -350.0%
Revenue Est (next Q) $5.4M
Revenue Growth Est (next Q) -1.9%
Fair Value Estimates
Graham Number $2.57
Graham Upside -75.0%
Lynch Fair Value $2.00
Lynch Upside -80.5%
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $5.89M
Free Cash Flow $4.21M
Adj. Free Cash Flow $3.66M
FCF Per Share $0.46
OCF Per Share $0.65
OCF/S Ratio 19.2%
Income Statement
Revenue $30.68M
Gross Profit $12.37M
Operating Income $3.87M
EBITDA $3.54M
Net Income $787.37K
EPS (Diluted) $0.08
Revenue / Employee $420.21K
Profit / Employee $10.79K
Employees 73
Add to Watchlist
Select watchlists to add or remove ICCC